Neonatal capsaicin treatment affects rat thymocyte proliferation and cell death by modulating substance P and neurokinin-1 receptor expression

被引:8
作者
Santoni, G
Amantini, C
Lucciarini, R
Perfumi, M
Pompei, P
Piccoli, M
机构
[1] Univ Camerino, Dept Pharmacol Sci & Expt Med, IT-62032 Camerino, Italy
[2] Univ Roma La Sapienza, Dept Expt Med & Pathol, Rome, Italy
[3] Univ Roma La Sapienza, Dept Human Physiol & Pharmacol, Rome, Italy
关键词
capsaicin; neuropeptides; thymocytes; substance P; neurokinin receptors; apoptosis; animal models; in vivo;
D O I
10.1159/000076765
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Herein we provide evidence that substance P (SP) and its neurokinin-1 receptor (NK-1R) expressed on thymocytes counteract thymus depletion induced by neonatal capsaicin (CPS) treatment by affecting thymocyte proliferation and apoptotic death. SP administration reversed the CPS-mediated inhibitory effects on the total thymocyte number and subset distribution, namely CD4+ and CD-4 CD8- cells, through its interaction with NK-1R as shown by concomitant NK-1R (SR140333) antagonist administration. SP-induced enhancement of thymus cellularity parallels its ability of inhibiting the thymocyte apoptotic program. Indeed, exogenously administered SP completely nullified CPS-induced apoptosis, and SR140333 abrogated the SP-mediated protective effect. SP administration also stimulated concanavalin A (Con A)-induced thymocyte proliferation of CPS-treated rats, completely reversing the CPS-induced inhibition. The SP-mediated stimulation of Con A-induced thymocyte proliferation was NK-1R dependent as shown by concomitant administration of SP and SR140333 to CPS-treated rats. Our results also demonstrate that CPS treatment induces a marked decrease of thymocyte PPT-A mRNA level and endogenous SP content as evaluated by quantitative RT-PCR, in situ hybridization and cytofluorimetric analysis. By contrast, NK-1R mRNA levels were increased in thymocytes from CPS-treated rats. Exogenous SP administration augmented PPT-A, SP and NK-1R thymocyte expression in CPS-treated rats, and this enhancement was antagonized by SR140333 administration. Overall, our results strongly suggest that the immunomodulatory effects of neonatal CPS treatment on rat thymocyte functions are dependent on vanilloid-mediated regulation of SP and NK-1R functional expression by neuronal and immune cells. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:160 / 172
页数:13
相关论文
共 50 条
  • [41] The emerging role of substance P/neurokinin-1 receptor signaling pathways in growth and development of tumor cells
    Javid, Hossein
    Mohammadi, Fariba
    Zahiri, Elnaz
    Hashemy, Seyed Isaac
    JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY, 2019, 75 (04) : 415 - 421
  • [42] Neurokinin-1 receptor and substance P messenger RNA levels increase during intraabdominal adhesion formation
    Reed, KL
    Fruin, AB
    Bishop-Bartolomei, KK
    Gower, AC
    Nicolaou, M
    Stucchi, AF
    Leeman, SE
    Becker, JM
    JOURNAL OF SURGICAL RESEARCH, 2002, 108 (01) : 165 - 172
  • [43] Suppression of autoimmune encephalomyelitis by a neurokinin-1 receptor antagonist - A putative role for substance P in CNS inflammation
    Nessler, Stefan
    Stadelmann, Christine
    Bittner, Alwina
    Schlegel, Kerstin
    Gronen, Felix
    Brueck, Wolfgang
    Hemmer, Bernhard
    Sommer, Norbert
    JOURNAL OF NEUROIMMUNOLOGY, 2006, 179 (1-2) : 1 - 8
  • [44] MODULATION OF SUBSTANCE-P NEUROKININ-1 RECEPTOR IN HUMAN ASTROCYTOMA-CELLS BY ANTISENSE OLIGODEOXYNUCLEOTIDES
    OGO, H
    HIRAI, Y
    MIKI, S
    NISHIO, H
    AKIYAMA, M
    NAKATA, Y
    GENERAL PHARMACOLOGY, 1994, 25 (06): : 1131 - 1135
  • [45] Substance P and Neurokinin-1 Receptor System in Thyroid Cancer: Potential Targets for New Molecular Therapies
    Isorna, Inmaculada
    Gonzalez-Moles, Miguel Angel
    Munoz, Miguel
    Esteban, Francisco
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (19)
  • [46] Substance P/Neurokinin-1 Receptor, Trigeminal Ganglion, Latency, and Coronavirus Infection-Is There Any Link?
    Mehboob, Riffat
    Kurdi, Maher
    Bamaga, Ahmed
    Aldardeir, Njoud
    Nasief, Hisham
    Moshref, Leena H.
    Alsinani, Taghreed
    Rayes, Almotasimbellah O.
    Jabbad, Reem H.
    FRONTIERS IN MEDICINE, 2021, 8
  • [47] Neurokinin-1 receptor activation is sufficient to restore the hypercapnic ventilatory response in the Substance P-deficient naked mole-rat
    Clayson, Maxwell S.
    Devereaux, Maiah E. M.
    Pamenter, Matthew E.
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2020, 318 (04) : R712 - R721
  • [48] Destruction of neurokinin-1 receptor expressing cells in vitro and in vivo using substance P-saporin in rats
    Wiley, RG
    Lappi, DA
    NEUROSCIENCE LETTERS, 1997, 230 (02) : 97 - 100
  • [49] Neurokinin type-1 receptor antagonist inhibits enhancement of T cell functions by substance P in normal and neuromanipulated capsaicin-treated rats
    Santoni, G
    Perfumi, MC
    Spreghini, E
    Romagnoli, S
    Piccoli, M
    JOURNAL OF NEUROIMMUNOLOGY, 1999, 93 (1-2) : 15 - 25
  • [50] Unveiling the Promising Role of Substance P/Neurokinin 1 Receptor in Cancer Cell Proliferation and Cell Cycle Regulation in Human Malignancies
    Rezaei, Soodabeh
    Javid, Hossein
    Iranpour, Sonia
    Darban, Reza Assaran
    Hashemy, Seyed Isaac
    CURRENT MEDICINAL CHEMISTRY, 2024,